These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 6464831

  • 1. The neuropharmacological effects of electroconvulsive shock and their relationship to the therapeutic effect of electroconvulsive therapy in depression.
    Grahame-Smith DG.
    Adv Biochem Psychopharmacol; 1984; 39():327-43. PubMed ID: 6464831
    [No Abstract] [Full Text] [Related]

  • 2. A role of some central neurotransmitter systems in the mechanism of electroconvulsive shock action.
    Kleinrok Z, Wielosz M.
    Pol J Pharmacol Pharm; 1985; 37(6):745-52. PubMed ID: 3008135
    [Abstract] [Full Text] [Related]

  • 3. Effects of electroconvulsive shock on monoaminergic systems in the rat brain. Thesis.
    Wielosz M.
    Pol J Pharmacol Pharm; 1983; 35(2):127-30. PubMed ID: 6684770
    [Abstract] [Full Text] [Related]

  • 4. Receptors and the mechanism of action of ECT.
    Lerer B, Belmaker RH.
    Biol Psychiatry; 1982 Apr; 17(4):497-511. PubMed ID: 6282347
    [No Abstract] [Full Text] [Related]

  • 5. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK, Dhir A.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):163-72. PubMed ID: 18585703
    [Abstract] [Full Text] [Related]

  • 6. The development of our understanding of the mechanism of action of antidepressant drugs.
    Vetulani J.
    Pol J Pharmacol Pharm; 1991 Jul 28; 43(4):323-38. PubMed ID: 1811223
    [No Abstract] [Full Text] [Related]

  • 7. [Neurochemical aspects of the emotional reactivity and motor activity of rats in new circumstances].
    Kulagin DA, Bolondinskiĭ VK.
    Usp Fiziol Nauk; 1986 Jul 28; 17(1):92-109. PubMed ID: 2420084
    [No Abstract] [Full Text] [Related]

  • 8. The involvement of serotonin and noradrenaline in the psychopathological processes of stress and depression: animal models and the effect of antidepressant drugs.
    Płaźnik A, Kostowski W.
    Pol J Pharmacol Pharm; 1991 Jul 28; 43(4):301-22. PubMed ID: 1811222
    [No Abstract] [Full Text] [Related]

  • 9. Interactions of 5-hydroxytryptamine and gamma-aminobutyric acid with dopamine.
    Pycock CJ, Horton RW, Carter CJ.
    Adv Biochem Psychopharmacol; 1978 Jul 28; 19():323-41. PubMed ID: 358783
    [No Abstract] [Full Text] [Related]

  • 10. [Functional role of transmitter systems in the brain].
    Guldberg HC.
    Tidsskr Nor Laegeforen; 1973 Jun 20; 93(17):1305-9. PubMed ID: 4148047
    [No Abstract] [Full Text] [Related]

  • 11. Electroconvulsive therapy and the brain: evidence for increased dopamine-mediated responses.
    Costain DW, Cowen PJ, Gelder MG, Grahame-Smith DG.
    Lancet; 1982 Aug 21; 2(8295):400-4. PubMed ID: 6124803
    [Abstract] [Full Text] [Related]

  • 12. The interrelationship between brain noradrenergic and dopaminergic neuronal systems in regulating animal behavior: possible clinical implications.
    Plaźnik A, Kostowski W.
    Psychopharmacol Bull; 1983 Aug 21; 19(1):5-11. PubMed ID: 6338550
    [No Abstract] [Full Text] [Related]

  • 13. Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice.
    Fuller RW, Hemrick-Luecke SK, Snoddy HD.
    J Pharmacol Exp Ther; 1994 Apr 21; 269(1):132-6. PubMed ID: 7513356
    [Abstract] [Full Text] [Related]

  • 14. The neurochemistry of behavior.
    Panksepp J.
    Annu Rev Psychol; 1986 Apr 21; 37():77-107. PubMed ID: 3963784
    [No Abstract] [Full Text] [Related]

  • 15. Brain noradrenergic neurons, their interactions and role in the action of antidepressive drugs.
    Kostowski W.
    Acta Physiol Pharmacol Bulg; 1982 Apr 21; 8(1-2):29-36. PubMed ID: 7124417
    [No Abstract] [Full Text] [Related]

  • 16. The antidepressant-like effect of Hypericum caprifoliatum Cham & Schlecht (Guttiferae) on forced swimming test results from an inhibition of neuronal monoamine uptake.
    Viana A, do Rego JC, von Poser G, Ferraz A, Heckler AP, Costentin J, Kuze Rates SM.
    Neuropharmacology; 2005 Dec 21; 49(7):1042-52. PubMed ID: 16040063
    [Abstract] [Full Text] [Related]

  • 17. Hippocampal glucocorticoid binding: serotoninergic regulation and drug effects; relevance to behavioral-endocrine activities and depression.
    Angelucci L, Patacchioli FR, Scaccianoce S, Martucci E, Capasso M.
    Ann Ist Super Sanita; 1982 Dec 21; 18(1):35-9. PubMed ID: 6892091
    [No Abstract] [Full Text] [Related]

  • 18. Neuroscience. Vehicles of inactivation.
    Snyder SH.
    Nature; 1991 Nov 21; 354(6350):187. PubMed ID: 1683684
    [No Abstract] [Full Text] [Related]

  • 19. [Effect of adjuvant drug therapy following successful electroconvulsive therapy for therapy-resistant depression is still disappointing].
    Leentjens AF, van den Broek WW, Birkenhäger TK, Moleman P, Bruijn JA.
    Ned Tijdschr Geneeskd; 1996 Feb 03; 140(5):241-3. PubMed ID: 8643129
    [No Abstract] [Full Text] [Related]

  • 20. Neurobiological correlates of the antidepressant action of electroconvulsive therapy.
    Mann JJ.
    J ECT; 1998 Sep 03; 14(3):172-80. PubMed ID: 9773356
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.